Home › Entities › clinical_trial › SILtuximab in Viral ARds (SILVAR) Study

SILtuximab in Viral ARds (SILVAR) Study

clinical trial
MedicalStudy clinical_trial Q106964746
Press Enter · cited answer in seconds

Summary

SILtuximab in Viral ARds (SILVAR) Study is a clinical trial[1].

Key Facts

  • SILtuximab in Viral ARds (SILVAR) Study is in the country of United States[2].
  • SILtuximab in Viral ARds (SILVAR) Study's instance of is recorded as clinical trial[3].
  • SILtuximab in Viral ARds (SILVAR) Study's start time is recorded as +2020-11-13T00:00:00Z[4].
  • SILtuximab in Viral ARds (SILVAR) Study's end time is recorded as +2021-04-01T00:00:00Z[5].
  • SILtuximab in Viral ARds (SILVAR) Study's main subject is recorded as siltuximab[6].
  • SILtuximab in Viral ARds (SILVAR) Study's number of participants is recorded as {'unit': '1', 'amount': '+555'}[7].
  • SILtuximab in Viral ARds (SILVAR) Study's title is recorded as A Study Comparing the Efficacy and Safety of Standard of Care With or Without Siltuximab in Selected Hospitalized Patients With Viral Acute Respiratory Distress Syndrome (SILVAR)[8].
  • SILtuximab in Viral ARds (SILVAR) Study's short name is recorded as SILVAR[9].
  • SILtuximab in Viral ARds (SILVAR) Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+12'}[10].
  • SILtuximab in Viral ARds (SILVAR) Study's ClinicalTrials.gov ID is recorded as NCT04616586[11].
  • SILtuximab in Viral ARds (SILVAR) Study's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}[12].
  • SILtuximab in Viral ARds (SILVAR) Study's research intervention is recorded as siltuximab[13].
  • SILtuximab in Viral ARds (SILVAR) Study's clinical trial phase is recorded as phase III clinical trial[14].
  • SILtuximab in Viral ARds (SILVAR) Study's research subject recruitment status is recorded as terminated[15].
  • SILtuximab in Viral ARds (SILVAR) Study's study type is recorded as interventional study[16].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). SILtuximab in Viral ARds (SILVAR) Study. Retrieved May 3, 2026, from https://4ort.xyz/entity/siltuximab-in-viral-ards-silvar-study
MLA “SILtuximab in Viral ARds (SILVAR) Study.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/siltuximab-in-viral-ards-silvar-study.
BibTeX @misc{4ortxyz_siltuximab-in-viral-ards-silvar-study_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{SILtuximab in Viral ARds (SILVAR) Study}}, year = {2026}, url = {https://4ort.xyz/entity/siltuximab-in-viral-ards-silvar-study}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): SILtuximab in Viral ARds (SILVAR) Study — https://4ort.xyz/entity/siltuximab-in-viral-ards-silvar-study (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/siltuximab-in-viral-ards-silvar-study · Last refreshed: